Session Information
Date: Tuesday, June 6, 2017
Session Title: Therapy in Movement Disorders
Session Time: 1:45pm-3:15pm
Location: Exhibit Hall C
Objective: To determine factors predicting treatment adherence in patients with idiopathic Parkinson’s disease.
Background: Parkinson’s disease is the second most common cause of neurodegenerative disease all around the world; and one of the challenges that physicians face is the poor adherence to treatment.
Methods: We designed a cross-sectional study in patients with Parkinson’s disease in which demographic and clinical data were collected. The following instruments were used: Hoehn & Yahr scale, Movement Disorder Society – Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), Parkinson’s disease questionnaire (PDQ-8), the European Quality of Life Questionnaire 5 level version (EQ-5D), the Spanish Chronic Disease Self-Efficacy scale, Morisky-Green test, Schwab & England Activities of Daily Living Scale (S&E) and a brief questionnaire about patient’s treatment.
Results: A total of 86 patients were included. We found a mean age of 61.98 ± 12.07 years & 62 (72.1% of the sample) were male. 46.5% & 32.6% had a Hoehn & Yahr score of 1 and 2, respectively. 52.3% had a mild MDS-UPDRS. 38.4% & 34.2% of patients were treated with monotherapy and combined therapy, respectively.
A statistically significant difference was found in patients with good self-efficacy (p=0.015) and with good quality of life (p=0.001). We found no significant relationship between sex, age, mental status, Parkinson’s disease duration, number of drugs taken, Hoehn & Yahr score nor the level of education. For non-parametric variables, we found a relationship with the S&E scale (p=0.028) (see Table 1).
Conclusions: These findings suggest that a good quality of life and a good self-efficacy predict a good adherence to treatment in patients with Parkinson’s disease.
References: 1. Shin JY, Habermann B. Medication Adherence in People With Parkinson Disease. J Neurosci Nurs. 2016 Jul-Aug;48(4):185-94.
2. Foppa AA, Chemello C, Vargas-Peláez CM, Farias MR. Medication Therapy Management Service for Patients with Parkinson’s Disease: A Before-and-After Study. Neurol Ther. 2016 Jun;5(1):85-99.
To cite this abstract in AMA style:
I. Estrada-Bellmann, C. Cerda-Contreras, J. Peña-Avendaño, D. Ortiz-Zacarías, P. Cortés-Estrada. Determinant factors of treatment adherence in Parkinson’s disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/determinant-factors-of-treatment-adherence-in-parkinsons-disease/. Accessed May 19, 2025.« Back to 2017 International Congress
MDS Abstracts - https://www.mdsabstracts.org/abstract/determinant-factors-of-treatment-adherence-in-parkinsons-disease/